As recorded in 2025, the Poland market amounted to USD 8.13 billion.
Our data-backed projections indicate the Poland Infusion Services Market to total USD 28.42 billion by 2033, with a forecast CAGR of 16.9% across the forecast timeframe.
EU-aligned reimbursement reform and oncology center expansion are increasing infusion access beyond major metropolitan hospitals, improving regional coverage.
Poland’s National Health Fund reports rising oncology treatment reimbursements, supporting accelerated infusion service growth relative to regional peers.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]